9-134767390-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000093.5(COL5A1):​c.2232+36C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0255 in 1,598,972 control chromosomes in the GnomAD database, including 582 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 46 hom., cov: 33)
Exomes 𝑓: 0.026 ( 536 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0170

Publications

5 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-134767390-C-T is Benign according to our data. Variant chr9-134767390-C-T is described in ClinVar as Benign. ClinVar VariationId is 255061.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0249 (3794/152258) while in subpopulation EAS AF = 0.0529 (273/5164). AF 95% confidence interval is 0.0477. There are 46 homozygotes in GnomAd4. There are 1868 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 3794 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.2232+36C>T intron_variant Intron 24 of 65 ENST00000371817.8 NP_000084.3
COL5A1NM_001278074.1 linkc.2232+36C>T intron_variant Intron 24 of 65 NP_001265003.1
COL5A1XM_017014266.3 linkc.2232+36C>T intron_variant Intron 24 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.2232+36C>T intron_variant Intron 24 of 65 1 NM_000093.5 ENSP00000360882.3
COL5A1ENST00000371820.4 linkc.2232+36C>T intron_variant Intron 24 of 65 2 ENSP00000360885.4

Frequencies

GnomAD3 genomes
AF:
0.0249
AC:
3793
AN:
152140
Hom.:
46
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0182
Gnomad ASJ
AF:
0.0182
Gnomad EAS
AF:
0.0529
Gnomad SAS
AF:
0.0236
Gnomad FIN
AF:
0.0321
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0258
Gnomad OTH
AF:
0.0292
GnomAD2 exomes
AF:
0.0264
AC:
6599
AN:
249828
AF XY:
0.0265
show subpopulations
Gnomad AFR exome
AF:
0.0235
Gnomad AMR exome
AF:
0.0186
Gnomad ASJ exome
AF:
0.0182
Gnomad EAS exome
AF:
0.0568
Gnomad FIN exome
AF:
0.0287
Gnomad NFE exome
AF:
0.0252
Gnomad OTH exome
AF:
0.0264
GnomAD4 exome
AF:
0.0256
AC:
36994
AN:
1446714
Hom.:
536
Cov.:
30
AF XY:
0.0256
AC XY:
18426
AN XY:
720464
show subpopulations
African (AFR)
AF:
0.0209
AC:
693
AN:
33142
American (AMR)
AF:
0.0184
AC:
823
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.0195
AC:
509
AN:
26054
East Asian (EAS)
AF:
0.0399
AC:
1583
AN:
39626
South Asian (SAS)
AF:
0.0244
AC:
2100
AN:
85964
European-Finnish (FIN)
AF:
0.0294
AC:
1559
AN:
53020
Middle Eastern (MID)
AF:
0.0108
AC:
60
AN:
5530
European-Non Finnish (NFE)
AF:
0.0254
AC:
27952
AN:
1098798
Other (OTH)
AF:
0.0286
AC:
1715
AN:
59900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1812
3624
5435
7247
9059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1042
2084
3126
4168
5210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0249
AC:
3794
AN:
152258
Hom.:
46
Cov.:
33
AF XY:
0.0251
AC XY:
1868
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.0218
AC:
905
AN:
41550
American (AMR)
AF:
0.0181
AC:
277
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0182
AC:
63
AN:
3470
East Asian (EAS)
AF:
0.0529
AC:
273
AN:
5164
South Asian (SAS)
AF:
0.0238
AC:
115
AN:
4826
European-Finnish (FIN)
AF:
0.0321
AC:
341
AN:
10608
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0258
AC:
1757
AN:
68016
Other (OTH)
AF:
0.0289
AC:
61
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
195
390
585
780
975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0264
Hom.:
13
Bravo
AF:
0.0232
Asia WGS
AF:
0.0390
AC:
137
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.3
DANN
Benign
0.37
PhyloP100
0.017
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45622539; hg19: chr9-137659236; COSMIC: COSV65671903; API